Privatizing and prescribing identity: How Canadian biotechnology firms capture queer, trans, and neurodivergent movements for profit

The pivot to telehealth through the COVID-19 pandemic spawned numerous private investor-owned virtual care firms, capitalizing on loopholes and outdated policies in Canada’s healthcare regulatory framework. Amidst neoliberal biocapitalism, these health technology firms are increasingly functioning as primary care providers to fill the growing gaps in care under austerity. Contemporary health companies co-opt identity politics and social movement rhetoric in their marketing, transforming…

via https://pubmed.ncbi.nlm.nih.gov/42139867/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1lqZ3NPYysePVKsoyz66mDSgu4veDGJwnUBS47TBQPoOuNZY5J&fc=None&ff=20260522011021&v=2.20.0


Post a Comment

Your email is never published nor shared. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>